Clinical Trials Directory

Trials / Completed

CompletedNCT01564940

Human Factors Usability Study of Ib2C Conception System

Human Factors Usability Study of Abbreviated Functional Use of the Intimate Bridge 2 Conception, Inc. Conception System

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Rinovum Women's Health, Inc. · Industry
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to obtain subjective feedback in a home use environment regarding usability and ease of use of the applicator and conception cap and the instructions for use. Data will be collected and evaluation to determine if the usability requirements of the conception system as determined by the usability specification have been met. The study will not involve sexual intercourse or delivery of any fluids to the cervix. The study will only involve use of the applicator to insert the cervical cap into the vagina, track it to the cervix and prepare and release the cervical cap (with removal string attached) onto the cervix. The conception cap will remain in place for no more than 6 hours.

Detailed description

The purpose of this study is to obtain subjective feedback in a home use environment regarding usability and ease of use of the applicator and conception cap and the instructions for use. Data will be collected and evaluation to determine if the usability requirements of the conception system as determined by the usability specification have been met. The study will not involve sexual intercourse or delivery of any fluids to the cervix. The study will only involve use of the applicator to insert the cervical cap into the vagina, track it to the cervix and prepare and release the cervical cap (with removal string attached) onto the cervix. The conception cap will remain in place for no more than 6 hours.

Conditions

Timeline

Start date
2011-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2012-03-28
Last updated
2012-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01564940. Inclusion in this directory is not an endorsement.